CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Clinical trial NCT07558434 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07558434
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia

Start date: 2026-04-01
Primary completion: 2028-12-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.